Revolutionizing Cancer Treatment: The Latest Advancements in CAR T Cell Therapy Vectors

Recent advancements in CAR T-cell therapy vectors focus on enhancing efficiency, safety, and targeting precision. Innovations include non-viral vectors, CRISPR-based gene editing, and improved lentiviral designs. These developments aim to reduce manufacturing costs, minimize side effects, and expand CAR T-cell therapy applications for solid tumors and autoimmune diseases.